ClinicalTrials.gg
CompletedNCT04373499V-TTG vs BIUpdated Apr 29, 2021

Virtual Teach-to-Goal Education vs. Brief Education for Children

An interventional study of Virtual Teach to Goal and Brief Intervention in Asthma, Bronchospasm and Shortness of Breath, sponsored by University of Chicago. Completed at 1 site in United States. Open to participants aged 5 Years to 10 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-04-29.

Sponsored by University of Chicago · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
5 Years to 10 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate the effectiveness of two different ways to teach hospitalized children how to use a metered dose inhaler and to follow-up after discharge home from the hospital to determine durability of the education.

Read the detailed description

Asthma is the most common chronic childhood condition and has significant adverse consequences. One in 12 United States children has asthma, resulting in 13.4 million missed school days, 1 million emergency department visits, and 140,000 hospitalizations annually.

A key barrier to self-management of asthma is improper use of respiratory inhalers, which limits disease control. Better inhaler technique is associated with improved asthma outcomes for children. Assessment and education of inhaler technique are recommended at all healthcare encounters, however it is limited in practice because it is resource intensive (both personnel and time) and lacks fidelity. Thus, low-resource interventions that accurately teach inhaler skills are needed to impact pediatric asthma outcomes.

Teach-to-Goal (TTG) is a patient-centered strategy that uses tailored rounds of teaching and assessments to ensure mastery of inhaler technique. Studies show it is effective but resource intensive. A "virtual TTG" (V-TTG) intervention represents an opportunity to deliver inhaler technique education with a high-fidelity, low-resource, and feasible strategy. The module utilizes innovative learning technology with video demonstrations and assessment questions to tailor education to each user; the cycles of assessment and education continues until satisfactory mastery is achieved.

This study evaluates the comparative effectiveness of this high-fidelity, low-resource, and feasible model (V-TTG) versus a standardized brief intervention that mimics usual care to deliver tailored inhaler technique education to children with severe asthma via a randomized clinical trial.

02

Conditions studied

  • Asthma
  • Bronchospasm
  • Shortness of Breath

Keywords

  • Inhaler
  • Education
  • Asthma
  • Learning
  • Module
  • Virtual Teach to Goal
03

In context

Asthma

4,841 studies on the registry are indexed under Asthma; 600 are open to participants now.

This study's enrollment of 70 is below the median of 78 across 3,341 interventional studies indexed under Asthma.

Browse Asthma studies →

Lead sponsor

University of Chicago is the lead sponsor of 924 studies on the registry; 185 are open to participants now.

Of its 103 completed or terminated interventional studies of FDA-regulated products, 72 (70%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. The child is between the ages of 5-10 years old
  2. The child is admitted for an asthma exacerbation, wheezing, or bronchospasm
  3. The child is admitted to the Pediatric Hospital Medicine Service at Comer Children's Hospital
  4. The child is prescribed albuterol

Exclusion criteria

Exclusion Criteria:

  1. The child/parent decline or unable to provide consent/assent, do not speak/read English
  2. The child cannot use an inhaler by themselves without a mask
  3. The child previously participated in this study
  4. The child is currently in the pediatric intensive care unit (PICU)
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
70 participants (actual)

Study arms

  • Experimental
    Virtual Teach-to-Goal (V-TTG)

    The RA will show the patient how to use the tablet to access the education module and be available for questions about the technology / tablet but not about the content. Within the module, the child will: * answer questions about how to use the inhaler as part of a pre-video assessment. * watch a video about how to correctly use a Metered Dose Inhaler (MDI) and spacer. * answer questions on the tablet to assess how well they understand how to use the inhaler. If a child answers any questions incorrectly, they will watch the video again and have another chance to answer the incorrect questions. The child will receive instruction by video one or multiple times (up to 3 times), depending on how much they understand after each round of instruction, as demonstrated by their responses to questions.

    Behavioral: Virtual Teach to Goal

  • Active comparator
    Brief Intervention (BI)

    The RA will give the patient a handout about inhaler technique and read the steps to the child.

    Behavioral: Brief Intervention

Interventions

  • BehavioralVirtual Teach to Goal

    Virtual Teach-to-Goal is an educational module that teaches children how to use their inhaler properly; this is done with an IPAD. In the module, the child will complete a series of questions as a pre-assessment, watch a video about how to use the inhaler properly, and then answer a series of questions as a post-assessment. If a child answers any questions incorrectly, they will watch the video again and have another chance to answer the incorrect questions. The child will receive instruction by video one or multiple times (up to 3 times), depending on how much they understand after each round of instruction, as demonstrated by their responses to questions.

    Also known as: VTTG

  • BehavioralBrief Intervention

    There is a handout that describes proper inhaler technique. The RA reads the handout to the child.

    Also known as: BI

06

What researchers measure

Primary outcomes

  1. Proportion of participants with metered dose inhaler (MDI) misuse immediately after V-TTG vs. BI education

    Evaluate effectiveness of V-TTG as compared to BI as measured by inhaler technique post-intervention. This will provide data on the short-term effectiveness of the interventions. Each patient's inhaler technique will be assessed using validated inhaler checklists by the trained assessor.

    Time frame: Initial study visit / baseline

Secondary outcomes

  1. Acceptability of V-TTG among children and parents based on Likert-scale questions (1-5)

    Questionnaires of children and parents immediately after completing the V-TTG intervention. Likert-scale questions will focus on whether children and parents like the V-TTG education, would be willing to use, and would recommend to a friend.

    Time frame: Initial study visit - after completing V-TTG intervention

  2. Usability of V-TTG among children and parents based on open-ended questions

    Interviews with children and parents immediately after completing the V-TTG intervention. Open-ended questions will be utilized to assess what children and parents like or do not like about the module and how it could be utilized in clinical settings, at home, at school.

    Time frame: Initial study visit - after completing V-TTG intervention

  3. Proportion of participants with metered dose inhaler (MDI) misuse in VTTG vs BI arms at 1 month after education

    Retention of proper inhaler technique skills

    Time frame: Follow-up visit at 1 month

  4. Self-efficacy: Questionnaire

    Questionnaire with Likert-scale questions (1-5) to assess self-efficacy about inhaler technique pre vs post intervention

    Time frame: Initial study visit - at baseline and immediately after intervention

07

Study locations

1 site
  • University of Chicago Medicine
    Chicago, Illinois 60637, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 29, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04373499
Collaborators
CHEST Foundation
Responsible party
Sponsor
First posted
May 4, 2020
Start date
Jan 16, 2019
Primary completion
Feb 27, 2020
Completion
Dec 31, 2020
Last update
Apr 29, 2021

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion